Mostrar el registro sencillo del ítem

dc.contributor.authorGonzález Lozano, Elena
dc.contributor.authorGarcía García, Jorge 
dc.contributor.authorGálvez Peralta, Julio Juan 
dc.contributor.authorHidalgo García, Laura 
dc.contributor.authorRodríguez Nogales, Alba 
dc.contributor.authorRodríguez Cabezas, María Elena 
dc.contributor.authorSánchez Santos, Manuel 
dc.date.accessioned2023-01-27T13:21:33Z
dc.date.available2023-01-27T13:21:33Z
dc.date.issued2022-12-13
dc.identifier.citationGonzález-Lozano, E... [et al.]. Novel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Disease. Nutrients 2022, 14, 5296. [https://doi.org/10.3390/nu14245296]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/79421
dc.description.abstractLactobacillus probiotics contained in dietary supplements or functional foods are wellknown for their beneficial properties exerted on host health and diverse pathological situations. Their capacity to improve inflammatory bowel disease (IBD) and regulate the immune system is especially remarkable. Although bacteria–host interactions have been thought to occur directly, the key role that extracellular vesicles (EVs) derived from probiotics play on this point is being unveiled. EVs are lipid bilayer-enclosed particles that carry a wide range of cargo compounds and act in different signalling pathways. Notably, these EVs have been recently proposed as a safe alternative to the utilisation of live bacteria since they can avoid the possible risks that probiotics may entail in vulnerable cases such as immunocompromised patients. Therefore, this review aims to give an updated overview of the existing knowledge about EVs from different Lactobacillus strains, their mechanisms and effects in host health and different pathological conditions. All of the information collected suggests that EVs could be considered as potential tools for the development of future novel therapeutic approaches.es_ES
dc.description.sponsorshipJunta de Andalucia CTS 164 PY20_01157es_ES
dc.description.sponsorshipInstituto de Salud Carlos III European Commission PI19/01058 European Commissiones_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEVses_ES
dc.subjectIBDes_ES
dc.subjectImmunomodulationes_ES
dc.subjectInflammation es_ES
dc.subjectLactobacilluses_ES
dc.subjectPostbioticses_ES
dc.subjectProbioticses_ES
dc.titleNovel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Diseasees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/nu14245296
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional